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Next-Generation Sequencing Identifies Mutations
of SMPX, which Encodes the Small Muscle Protein,
X-Linked, as a Cause of Progressive Hearing Impairment
Margit Schraders,1,2,3,7 Stefan A. Haas,4,7 Nicole J.D. Weegerink,1,3,7 Jaap Oostrik,1,2,3 Hao Hu,5
Lies H. Hoefsloot,6 Sriram Kannan,2,6 Patrick L.M. Huygen,1 Ronald J.E. Pennings,1,3
Ronald J.C. Admiraal,1,3 Vera M. Kalscheuer,5,8 Henricus P.M. Kunst,1,3,8 and Hannie Kremer1,2,3,6,8,*
In a Dutch family with an X-linked postlingual progressive hearing impairment, a critical linkage interval was determined to span
a region of 12.9 Mb flanked by the markers DXS7108 and DXS7110. This interval overlaps with the previously described DFNX4 locus
and contains 75 annotated genes. Subsequent next-generation sequencing (NGS) detected one variant within the linkage interval,
a nonsense mutation in SMPX. SMPX encodes the small muscle protein, X-linked (SMPX). Further screening was performed on 26 index
patients from small families for whichX-linked inheritance of nonsyndromic hearing impairment (NSHI) was not excluded.We detected
a frameshift mutation in SMPX in one of the patients. Segregation analysis of both mutations in the families in whom they were found
revealed that themutations cosegregated with hearing impairment. Although we show that SMPX is expressed inmany different organs,
including the human inner ear, no obvious symptoms other than hearing impairment were observed in the patients. SMPX had previ-
ously been demonstrated to be specifically expressed in striated muscle and, therefore, seemed an unlikely candidate gene for hearing
impairment. We hypothesize that SMPX functions in inner ear development and/or maintenance in the IGF-1 pathway, the integrin
pathway through Rac1, or both.Hereditary nonsyndromic hearing impairment (NSHI) is
genetically extremely heterogeneous, as is illustrated by
the currently associated genes, numbering more than 50,
and the large number of loci for which the gene harboring
the causative mutation(s) is still elusive (Hereditary Hearing
Loss Homepage).1 This hampers DNA diagnostics and
adequate mutation-based genetic counseling. Inheritance
patterns of monogenic NSHI can be (in order of decreasing
prevalence) autosomal recessive, autosomal dominant,
X-linked, or mitochondrial, and digenic inheritance has
also been indicated.2,3 Age-related hearing loss is a complex
disorder, although variants in genes involved inmonogenic
forms of NSHI have been found to be among the genetic
factors.4 Genes in which variation is associated with deaf-
ness have a wide variety of functions and have contributed
significantly to our understanding of themolecular biology
of hearing.1,5 Because of this functional diversity, bioinfor-
matic tools such as ENDEAVOUR or Prospectr have been of
limited value in the positional cloning of deafness genes.6
Currently,next-generation sequencing (NGS) is anexcellent
strategy for identification of disease-causing variants.7,8 In
the present study, we identified mutations in the gene
encoding the small muscle protein, X-linked (SMPX [MIM
300226]) as a cause of nonsyndromic hearing impairment
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committee of the Radboud University Nijmegen Medical
Centre and adhered to the tenets of the Declaration of Hel-
sinki. Written informed consent was obtained from all
subjects or, in case of children, from their parents. Affected
subjects of a large, five-generation family (W08-1701) of
Dutch origin presented with postlingual progressive
hearing impairment (Figure 1). An X-linked pattern of
inheritance was suggested by the absence of male-to-
male transmission and the fact that hearing impairment
developed earlier and was more severe in men than in
women. The majority of affected family members reported
bilateral, (slowly) progressive hearing impairment. Pure-
tone audiometry and otoscopy were performed for all de-
picted individuals by standard procedures. There was no
evidence for nongenetic causes of hearing impairment
except for individual III.3, who reported noise exposure.
Also, hearing impairment in this individual was less severe
and had a late onset at about age 60. The reported age at
which hearing impairment was first noticed was 2–10 years
old for men (with a mean of 3.3 years old) and 3–48 years
old for women (with a mean of 28.2 years old). In males,
the largest increase of threshold values occurred in the first
two decades, and progression to profound hearing impair-
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Figure 1. Pedigrees and Genetic Analyses
Only those familymembers of the large pedigree whowere relevant for the study are depicted. The haplotype associatedwith the hearing
impairment is indicated by the gray bar. In individual V.1, allele 3 of marker DXS1043might be derived from the affected haplotype. The
segregation of the c.214G>T is presented above the haplotypes. Family W08-1701 is of Dutch origin and family W05-049 is of
Netherlands Antilles’ origin. The following symbols are used: black squares, affected males; black circles, affected females; half-shaded
circles, females with unilateral hearing impairment; half-shaded square, male with unilateral hearing impairment; gray shaded square,
male with hearing impairment less severe than the other affected males.affected males (Figure 2). Hearing impairment in women
exhibited a large interindividual variation with regard to
the severity and also with regard to interaural variation
(Figure 2). Brainstem Evoked Response Audiometry
(BERA) for the proband, individual V.2, revealed normal
waveform responses at an intensity level of 45 dB. There
was no indication of conductive hearing impairment.
Furthermore, pure-tone audiometry never revealed a persis-
tent air-bone gap or pseudoconductive hearing impair-
ment in any of the affected family members (Figure S2,
available online). A more detailed description of the audio-
metric evaluation of the family will be reported elsewhere.
Genetic studies in this familywere initiatedby linkageanal-
ysis for the known X-chromosomal NSHI loci, recently re-
named DFNX1-5 (Hereditary Hearing Loss Homepage).9–13
Twenty-eight individuals from this family were genotyped
for microsatellite markers from the loci DFNX1 (MIM
304500), DFNX3 (MIM 300030), and DFNX4 (MIM
300066) (Table S1). After exclusion of DFNX1 and DFNX3,
evidence of linkage with the disease was found for marker
DXS8022, derived from the DFNX4 locus that was previ-The Ameously described as DFN6 for a family with similar audio-
metric features.12 Subsequentgenotypingofnineadditional
markers defined a critical region of 12.9 Mb flanked by the
markers DXS7108 and DXS7110 (Figure 1). In this region,
chrX:10,192,226-23,111,851, 75 genes have been anno-
tated (UCSC Genome Browser, hg19). We calculated two-
point LOD scores with SuperLink version 1.6 in the Easy-
Linkage software package by using the genotypes of males
only.14,15 Penetrance was assumed to be 99%, and a disease
allele frequency of 0.001was employed for the calculations.
Individual III.3 was included in the calculations as an
individual with an unknown phenotype. A significant
maximum LOD score of 4.87 (q ¼ 0.000) was obtained for
marker DXS8022; LOD scores are presented in Table S2.
Three candidate genes, PRPS2 (MIM 311860), SHROOM2
(MIM 300103), and GPM6B (MIM 300051), were selected
for a mutation search by conventional Sanger sequencing
because of homology with a known deafness gene or
expression in the inner ear, but no pathogenic variant
was identified. Subsequently, we performed targeted
enrichment by using the Agilent SureSelect Humanrican Journal of Human Genetics 88, 628–634, May 13, 2011 629
Figure 2. Audiometric Characteristics of the Families
(A) Representative audiograms (air conduction) of affected men (showing the means of thresholds of the left and right ears) and women
(thresholds of left (x) and right ear (o) shown separately) of family W08-1701 demonstrate progressive hearing loss in males within the
first two decades and the variability of the hearing loss in females.
(B) Representative audiograms of individual IV.1 from familyW05-049 at different ages (means of thresholds of the left and right ears are
shown). Pure-tone audiometry was performed in a sound-treated room according to current clinical standards. y is an abbreviation for
years.X Chromosome Kit and single-read 76 nt NGS on the Illu-
mina GAII sequencer for individual III.4.16 In total,
28,363,277 reads were obtained, of which 23,339,533
could be mapped, and 95.1% of the targeted bases were
covered at least 10-fold. After analysis of the sequence
data with in-house-developed tools and filtering of the pre-
dicted sequence variants against dbSNP, the 1000 Genome
Project, and 200 Danish control individuals,17 two variants
remained, chrX:117960412T>G and chrX:21755734C>A
(base-pair positions according to the NCBI37/hg19
assembly of the human genome), and only the latter was
located within the critical region. This variant, c.214G>T,
is located in exon 4 of SMPX (NM_014332.1) and intro-
duces a premature stop codon predicted to result in a trun-
cated protein after residue 71 (p.Glu72X). The presence of
this candidate disease-causing variant was confirmed by
Sanger sequencing in the affected males III.1, III.4, and
V.2 and a female carrier, IV.10 (Figure 3).
The c.214G>T transversion removes a restriction site for
Hpy188I. Therefore, we performed restriction digestion of
exon 4 amplicons according to the manufacturer’s
protocol (New England Biolabs) to test all family members
and ethnically matched controls for the presence of the
mutation. DNA fragments were analyzed on 2% agarose
gels (Figure S1). None of the 172 control individuals carried
the mutation, whereas in the family, the mutation was
found to fully cosegregate with hearing impairment in
males, as expected from the linkage analysis, and indi-
vidual III.3 indeed did not carry the mutation (Figure 1).
Therefore, his hearing impairment might well be caused630 The American Journal of Human Genetics 88, 628–634, May 13,by the reported noise exposure. For females the mutation
also coincides with the mutation-carrying haplotype, indi-
cating that individual IV.18 is either a phenocopy or
a genocopy. She has a mild increase in thresholds in the
pure-tone audiogram for the frequencies 0.25–1 kHz. On
the other hand, individual IV.15 shows no signs of hearing
impairment but does carry the mutation as does her twin
sister (monozygotic). The latter exhibits unilateral hearing
impairment. Both sisters were 25 years old at the last visit
in the clinic, and because the age at onset for females from
this family is variable (3–48 years), individual IV.15 could
well develop hearing impairment in the coming years.
To investigate the involvement of SMPX in other fami-
lies with hearing impairment, we performed Sanger
sequencing of the three protein-coding exons (2–4) and
the flanking intronic sequences in 26 index patients of
small families for which X-linked inheritance of NSHI
was not excluded. Sequence analysis was performed as
described,18 and primer sequences and conditions for
PCR amplification are provided in Table S3. In one of the
index patients (individual VI.1 of family W05-049,
Figure 1), a deletion of a single base pair, c.130delG, was
found in exon 3. This variant leads to a frameshift and
a premature stop codon, p.Glu44ArgfsX37. The patient’s
mother (III.2 in Figure 1) was found to carry the deletion
as well. No DNA samples from other family members
were available for testing. The mutation was not detected
in 129 Dutch control individuals who are not ethnicity
matched because the family is of Netherlands Antilles’
origin. Audiograms of the index patient are presented in2011
Figure 3. Mutation and Expression Analysis of SMPX
(A and B) Partial SMPX sequence chromatograms are shown for normal controls (upper panels), affected males (middle panels), and
female carriers (bottom panels). The predicted amino acid changes and the surrounding amino acids are indicated above the sequence.
Mutated nucleotides are marked by an arrowhead. As a reference, we employed sequence NM_014332.1 by using the first ATG transla-
tion initiation codon for numbering of the nucleotide change.
(C and D) Relative SMPXmRNA expression as determined by quantitative PCR in fetal (C) and adult (D) human tissues. Because this was
performed for adult and fetal tissues in two separate experiments, fetal inner ear was included in both for comparison.Figure 2B. Hearing impairment was first suspected around
the age of 4 and has progressed since then (Figure 2). No
air-bone gap was detected (Figure S2), and BERA revealed
normal waveform responses at 65 dB. The proband’s
mother (III.2 in Figure 1) did not report any signs of
hearing impairment at her last visit at clinic at the age of
38. Also, no hearing impairment was reported for obligate
female carriers in the previous generations. In an indepen-
dent study of two additional families with X-linked
hearing impairment, two different truncating mutations
have been detected in SMPX. The family in which the
DFNX4 locus was determined was one of these.12 The
results are presented in the accompanying paper by Hueb-
ner et al. in this issue.19
Because of its high and preferential expression in striated
muscle, SMPX was not an obvious candidate for NSHI.20,21
As a first step to identify a function of SMPX in the inner
ear, we analyzed SMPX transcription by RT-PCR on RNA
isolated from human inner ear of an embryo at 8 weeks
gestation. Indeed, SMPX mRNA could easily be amplified
and sequence verified (data not shown). Further evidence
for SMPX expression in the inner ear is provided by RNA
in situ hybridization in the mouse embryos at 14.5 days
of gestation (Eurexpress database assay 006968 and Gene-
paint assay DC27). In addition to being present in devel-
oping muscle, Smpx transcripts are present in a region
that presumably corresponds to the developing sensory
epithelium of the vestibular organs. Immunohistochem-The Ameistry with an Smpx antibody on sections of an adult
mouse’s organ of Corti revealed staining in different cell
types, including Bo¨ttcher cells, root cells, pillar cells, and
interdental cells of the limbus spiralis. Low levels of stain-
ing were detected in hair cells.19 Transcription of SMPXwas
further addressed by quantitative PCR (qPCR) on cDNA
derived from various fetal and adult human tissues as
described previously (Table S3).18 In Figure 3 the relative
amounts of SMPX transcripts in the tissues as compared
to that in the spleen (set to 1) are depicted. The house-
keeping gene GUSB (MIM 611499) was used as a reference
gene. SMPX mRNA levels were highest in both fetal and
adult skeletal muscle and heart, which is in agreement
with previous studies.20,22 No transcripts were detected
in fetal brain or in adult kidney and spleen tissues. Impor-
tantly, relatively high SMPX transcript levels are detected
in fetal inner ears, which supports the involvement of
SMPX in X-linked NSHI. Retinas derived from adult hu-
mans also exhibits a relatively high level of SMPX tran-
scripts. Despite the indications for significant expression
levels of SMPX in heart skeletal muscles and retinas, no
clear symptoms indicating an adverse effect of a truncating
SMPX mutation in these tissues are reported by affected
individuals from family W08-1701. Although one of the
males reported mild muscle injury upon heavy exercise,
a causative link to a defective SMPX remains to be deter-
mined by detailed testing of muscle function. No informa-
tion is available for family W05-049. For heart and skeletalrican Journal of Human Genetics 88, 628–634, May 13, 2011 631
muscle, functional redundancy was already indicated by
studies of a conditional knock-out allele of Smpx in
mice.22 This conditional knockout allele appeared to be
null because immunoblot analysis revealed no detectable
Smpx protein. However, the knockout mice displayed no
overt developmental or structural deficits in their skeletal
muscles or hearts, suggesting a genetic or functional
redundancy.
Smpx, previously also called Csl, is proline-rich and was
described to contain a nuclear localization signal, two
casein kinase II phosphorylation sites, and a proline, gluta-
mic acid, serine, and threonine-rich (PEST) sequence that
suggests Smpx undergoes rapid degradation.20 From late-
fetal to neonatal stages of murine cardiac- and skeletal-
muscle development onward, Smpx becomes associated
with the costameres.22 Costameres are subsarcolemmal
protein assemblies at the sarcomere-sarcolemma attach-
ment sites.23 Three actin-associated costameric protein
complexes have been distinguished: the focal adhesion-
type complexes, the spectrin-based complex, and the dys-
trophin-based complex, all of which tether molecules that
control, among other processes, mechanoreception and
cytoskeletal remodeling.24 Smpx is likely to be part of the
actin-associated complex because it was found, upon
expression in mouse myoblasts, to influence actin turn-
over and to induce lamellipodia in a Rac1-dependent
manner.22,25 Furthermore, Smpx colocalizes with focal
adhesion proteins at the membrane of these lamellipodia,
suggesting a link to integrin signaling.25 Interestingly,
both Rac1 and integrins (a8b1) are essential for normal
cochlear development and function.26,27 Conditional
inactivation of Rac1 (MIM 602048) leads to a shortened
cochlea and abnormal cellular organization of the sensory
epithelium. Furthermore, planar cell polarity of cochlear
hair cells and the morphogenesis of the hair bundle are
affected.26 Integrin (type a8b1) was found to be essential
for normal hair-bundle development and/or maintenance
and colocalizes with its ligand fibronectin and the integ-
rin-regulated focal adhesion kinase in the apical region of
developing vestibular hair cells.27 On the basis of all these
data, we hypothesize that Smpx functions in the develop-
ment and/or maintenance of the sensory hair cells.
A second link between SMPX and cochlea development
and function is provided by IGF-1 (MIM 147440). Smpx
modifies cell shape and promotes myocyte fusion when
expressed in C2C12 mouse myogenic cells in an IGF-1
dependent manner.22 Igf-1-deficient mice have multiple
cochlear abnormalities, including an abnormal differentia-
tion, a reduced survival of spiral ganglia neurons, and an
abnormal tectorial membrane.28,29 MEF2 (MIM 600663)
has been indicated to be a target gene of IGF-1 in the
mouse cochlea in both the sensory cells and the spiral
ganglia neurons. Interestingly, the IGF-1-mediated
increase of MEF2 activity in myoblasts is augmented by
Smpx.22 Furthermore, the consensus sequence for MEF2
binding is present twice in the highly conserved 50
upstream region of SMPX.20 IGF1 mutations in humans632 The American Journal of Human Genetics 88, 628–634, May 13,cause syndromic, severe to profound, and congenital or
very early-onset sensorineural hearing impairment (MIM
608747).30–32 This inner ear phenotype is more severe
than that in the families included in this study.
In-depth studies are required for the discernment of
which cell types and pathways in the cochlea are affected
by mutations in SMPX. Fast deterioration of hearing in the
first decades of life, as seen in familyW08-1701, has been re-
ported previously for patients with mutations in a number
of genes, including ACTG1 (MIM 102560) encoding the
cytoskeletal g-1-actin.33,34 Interestingly, this is thought to
be the major cytoskeletal actin in costameres.35
In conclusion, this study identifies SMPX as a gene in
which variation is associated with X-linked deafness and
illustrates that NGS is instrumental in the efficient identi-
fication of disease-causing variants in unexpected genes.
Our results will contribute to adequate mutation-based
genetic counseling of patients and their relatives. Because
females can be affected, although generally not in child-
hood, SMPX should also be considered in small pedigrees
with dominantly inherited hearing impairment and those
pedigrees in which X-linked inheritance cannot be
excluded. Further analysis of the function of SMPX will
provide insights into inner ear development and function,
and SMPX might well be a player in the regulation of ster-
eocilia development and/or maintenance.Supplemental Data
Supplemental Data include two figures and three tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
We thank the families for their participation in this study. We
would like to thank Suzanne Granneman for her contribution to
the linkage analysis; Anne-Katrin Emde, Sean O’Keeffe, and Wei
Chen for their help with establishing the bioinformatic tools;
Claudia Langnick for construction of the single-end Illumina
sequencing library; and Corinna Jensen and Melanie Bienek for
NGS. The work was financially supported by the Heinsius
Houbolt Foundation, the INTERREG IV A-program Germany-the
Netherlands, The Oticon Foundation (09-3742), the Netherlands
Genomics Initiative (40-41009-98-9073), and ZonMW (40-
00812-98-09047).
Received: February 26, 2011
Revised: April 7, 2011
Accepted: April 18, 2011
Published online: May 5, 2011Web Resources
The URLs for data presented herein are as follows:
1000 Genome Project, http://www.1000genomes.org/
Eurexpress, A Transcriptome Atlas Database for Mouse Embryo,
http://www.eurexpress.org/ee/
Genepaint, a Digital Atlas of Gene Expression Patterns in the
Mouse, http://www.genepaint.org2011
Hereditary Hearing Loss Homepage, http://hereditaryhearingloss.
org/
Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.
gov/Omim
UCSC Human Genome Browser, Build hg19, March 2006, http://
www.genome.ucsc.eduReferences
1. Dror, A.A., and Avraham, K.B. (2010). Hearing impairment: A
panoply of genes and functions. Neuron 68, 293–308.
2. Liu, X.Z., Yuan, Y., Yan, D., Ding, E.H., Ouyang, X.M., Fei, Y.,
Tang, W., Yuan, H., Chang, Q., Du, L.L., et al. (2009). Digenic
inheritance of non-syndromic deafness caused by mutations
at the gap junction proteins Cx26 and Cx31. Hum. Genet.
125, 53–62.
3. Yang, T., Gurrola, J.G., 2nd, Wu, H., Chiu, S.M., Wangemann,
P., Snyder, P.M., and Smith, R.J. (2009). Mutations of KCNJ10
together with mutations of SLC26A4 cause digenic nonsyn-
dromic hearing loss associated with enlarged vestibular aque-
duct syndrome. Am. J. Hum. Genet. 84, 651–657.
4. Van Laer, L., Van Eyken, E., Fransen, E., Huyghe, J.R., Topsakal,
V., Hendrickx, J.J., Hannula, S., Ma¨ki-Torkko, E., Jensen, M.,
Demeester, K., et al. (2008). The grainyhead like 2 gene
(GRHL2), alias TFCP2L3, is associated with age-related hearing
impairment. Hum. Mol. Genet. 17, 159–169.
5. Richardson, G.P., de Monvel, J.B., and Petit, C. (2011). How
the genetics of deafness illuminates auditory physiology.
Annu. Rev. Physiol. 73, 311–334.
6. Oti, M., Huynen, M.A., and Brunner, H.G. (2009). The biolog-
ical coherence of human phenome databases. Am. J. Hum.
Genet. 85, 801–808.
7. Rehman, A.U., Morell, R.J., Belyantseva, I.A., Khan, S.Y., Boger,
E.T., Shahzad,M., Ahmed, Z.M., Riazuddin, S., Khan, S.N., Ria-
zuddin, S., and Friedman, T.B. (2010). Targeted capture and
next-generation sequencing identifies C9orf75, encoding ta-
perin, as the mutated gene in nonsyndromic deafness
DFNB79. Am. J. Hum. Genet. 86, 378–388.
8. Walsh, T., Shahin, H., Elkan-Miller, T., Lee, M.K., Thornton,
A.M., Roeb, W., Abu Rayyan, A., Loulus, S., Avraham, K.B.,
King, M.C., and Kanaan, M. (2010). Whole exome sequencing
and homozygosity mapping identify mutation in the cell
polarity protein GPSM2 as the cause of nonsyndromic hearing
loss DFNB82. Am. J. Hum. Genet. 87, 90–94.
9. Tyson, J., Bellman, S., Newton, V., Simpson, P., Malcolm, S.,
Pembrey, M.E., and Bitner-Glindzicz, M. (1996). Mapping of
DFN2 to Xq22. Hum. Mol. Genet. 5, 2055–2060.
10. de Kok, Y.J., van der Maarel, S.M., Bitner-Glindzicz, M., Huber,
I., Monaco, A.P., Malcolm, S., Pembrey, M.E., Ropers, H.H.,
and Cremers, F.P. (1995). Association between X-linked mixed
deafness and mutations in the POU domain gene POU3F4.
Science 267, 685–688.
11. Lalwani, A.K., Brister, J.R., Fex, J., Grundfast, K.M., Pikus, A.T.,
Ploplis, B., San Agustin, T., Skarka, H., andWilcox, E.R. (1994).
A new nonsyndromic X-linked sensorineural hearing impair-
ment linked to Xp21.2. Am. J. Hum. Genet. 55, 685–694.
12. del Castillo, I., Villamar, M., Sarduy, M., Romero, L., Herraiz,
C., Herna´ndez, F.J., Rodrı´guez, M., Borra´s, I., Montero, A., Bel-
lo´n, J., et al. (1996). A novel locus for non-syndromic sensori-
neural deafness (DFN6) maps to chromosome Xp22. Hum.
Mol. Genet. 5, 1383–1387.The Ame13. Wang, Q.J., Li, Q.Z., Rao, S.Q., Lee, K., Huang, X.S., Yang,W.Y.,
Zhai, S.Q., Guo, W.W., Guo, Y.F., Yu, N., et al. (2006). AUNX1,
a novel locus responsible for X linked recessive auditory and
peripheral neuropathy, maps to Xq23-27.3. J. Med. Genet.
43, e33.
14. Lindner, T.H., and Hoffmann, K. (2005). easyLINKAGE: A
PERL script for easy and automated two-/multi-point linkage
analyses. Bioinformatics 21, 405–407.
15. Fishelson, M., and Geiger, D. (2002). Exact genetic linkage
computations for general pedigrees. Bioinformatics 18
(Suppl 1 ), S189–S198.
16. Johnston, J.J., Teer, J.K., Cherukuri, P.F., Hansen, N.F., Loftus,
S.K., Chong, K., Mullikin, J.C., and Biesecker, L.G.; NIH Intra-
mural Sequencing Center (NISC). (2010). Massively parallel
sequencing of exons on the X chromosome identifies
RBM10 as the gene that causes a syndromic form of cleft
palate. Am. J. Hum. Genet. 86, 743–748.
17. Li, Y., Vinckenbosch, N., Tian, G., Huerta-Sanchez, E., Jiang,
T., Jiang, H., Albrechtsen, A., Andersen, G., Cao, H., Kornelius-
sen, T., et al. (2010). Resequencing of 200 human exomes
identifies an excess of low-frequency non-synonymous
coding variants. Nat. Genet. 42, 969–972.
18. Schraders, M., Lee, K., Oostrik, J., Huygen, P.L., Ali, G., Hoef-
sloot, L.H., Veltman, J.A., Cremers, F.P., Basit, S., Ansar, M.,
et al. (2010). Homozygosity mapping reveals mutations of
GRXCR1 as a cause of autosomal-recessive nonsyndromic
hearing impairment. Am. J. Hum. Genet. 86, 138–147.
19. Huebner, A., Gandia, M., Frommolt, P., Maak, A., Wicklein, E.,
Thiele, H., Altmu¨ller, J., Wagner, F., Vin˜uela, L., Aguirre, L.A.,
et al. (2011). Nonsense mutations in SMPX, encoding a protein
responsive to physical force, result in X-chromosomal hearing
loss (DFNX4). Am. J. Hum. Genet. 88, this issue, 621–627.
20. Kemp, T.J., Sadusky, T.J., Simon, M., Brown, R., Eastwood, M.,
Sassoon, D.A., and Coulton, G.R. (2001). Identification of
a novel stretch-responsive skeletal muscle gene (Smpx). Geno-
mics 72, 260–271.
21. Patzak, D., Zhuchenko, O., Lee, C.C., andWehnert, M. (1999).
Identification, mapping, and genomic structure of a novel X-
chromosomal human gene (SMPX) encoding a small
muscular protein. Hum. Genet. 105, 506–512.
22. Palmer, S., Groves, N., Schindeler, A., Yeoh, T., Biben, C.,
Wang, C.C., Sparrow, D.B., Barnett, L., Jenkins, N.A., Cope-
land, N.G., et al. (2001). The small muscle-specific protein
Csl modifies cell shape and promotes myocyte fusion in an
insulin-like growth factor 1-dependent manner. J. Cell Biol.
153, 985–998.
23. Kee, A.J., Gunning, P.W., and Hardeman, E.C. (2009). Diverse
roles of the actin cytoskeleton in striated muscle. J. Muscle
Res. Cell Motil. 30, 187–197.
24. Clark,K.A.,McElhinny,A.S., Beckerle,M.C., andGregorio,C.C.
(2002). Striated muscle cytoarchitecture: An intricate web of
form and function. Annu. Rev. Cell Dev. Biol. 18, 637–706.
25. Schindeler, A., Lavulo, L., and Harvey, R.P. (2005). Muscle cos-
tameric protein, Chisel/Smpx, associates with focal adhesion
complexes and modulates cell spreading in vitro via a Rac1/
p38 pathway. Exp. Cell Res. 307, 367–380.
26. Grimsley-Myers, C.M., Sipe, C.W., Ge´le´oc, G.S., and Lu, X.
(2009). The small GTPase Rac1 regulates auditory hair cell
morphogenesis. J. Neurosci. 29, 15859–15869.
27. Littlewood Evans, A., andMu¨ller, U. (2000). Stereocilia defects
in the sensory hair cells of the inner ear in mice deficient in
integrin alpha8beta1. Nat. Genet. 24, 424–428.rican Journal of Human Genetics 88, 628–634, May 13, 2011 633
28. Camarero, G., Avendano, C., Fernandez-Moreno, C., Villar, A.,
Contreras, J., de Pablo, F., Pichel, J.G., and Varela-Nieto, I.
(2001). Delayed inner ear maturation and neuronal loss in
postnatal Igf-1-deficient mice. J. Neurosci. 21, 7630–7641.
29. Camarero, G., Villar, M.A., Contreras, J., Ferna´ndez-Moreno,
C., Pichel, J.G., Avendan˜o, C., and Varela-Nieto, I. (2002).
Cochlear abnormalities in insulin-like growth factor-1 mouse
mutants. Hear. Res. 170, 2–11.
30. Sanchez-Calderon, H., Rodriguez-de la Rosa, L., Milo, M., Pi-
chel, J.G., Holley, M., and Varela-Nieto, I. (2010). RNA micro-
array analysis in prenatal mouse cochlea reveals novel IGF-I
target genes: Implication of MEF2 and FOXM1 transcription
factors. PLoS ONE 5, e8699.
31. Woods, K.A., Camacho-Hu¨bner, C., Savage, M.O., and Clark,
A.J. (1996). Intrauterine growth retardation and postnatal
growth failure associated with deletion of the insulin-like
growth factor I gene. N. Engl. J. Med. 335, 1363–1367.634 The American Journal of Human Genetics 88, 628–634, May 13,32. Bonapace, G., Concolino, D., Formicola, S., and Strisciuglio,
P. (2003). A novel mutation in a patient with insulin-like
growth factor 1 (IGF1) deficiency. J. Med. Genet. 40,
913–917.
33. Zhu, M., Yang, T., Wei, S., DeWan, A.T., Morell, R.J., Elfenbein,
J.L., Fisher, R.A., Leal, S.M., Smith, R.J., and Friderici, K.H.
(2003). Mutations in the gamma-actin gene (ACTG1) are asso-
ciated with dominant progressive deafness (DFNA20/26). Am.
J. Hum. Genet. 73, 1082–1091.
34. Kemperman, M.H., De Leenheer, E.M., Huygen, P.L., van
Wijk, E., van Duijnhoven, G., Cremers, F.P., Kremer, H., and
Cremers, C.W. (2004). A Dutch family with hearing loss linked
to the DFNA20/26 locus: Longitudinal analysis of hearing
impairment. Arch. Otolaryngol. Head Neck Surg. 130,
281–288.
35. Ervasti, J.M. (2003). Costameres: The Achilles’ heel of Hercu-
lean muscle. J. Biol. Chem. 278, 13591–13594.2011
